算力商业
techcrunch.com ·
@Marina Temkin
Enveda 融资 3.11 亿美元，推动更多天然来源 AI 药物进入临床试验
AI 生物技术公司 Enveda 完成 3.11 亿美元 E 轮融资，估值达 20 亿美元，由 Catalio Capital Management 领投，Iconiq 等参投，估值较一年前翻倍。公司由 Recursion Pharmaceuticals 早期员工 Viswa Colluru 于 2019 年创立，思路是用 AI 等技术从植物和微生物中加速发现药物，而非完全在实验室合成。目前其多款候选药物正在患者中测试，包括一款针对严重皮肤病的药物，以及一款用于帮助停用 GLP-1 后维持减重的药物。报道同时指出，AI 迄今尚未产出任何获 FDA 批准的药物。
AI推荐理由 TechCrunch 报道的融资事实明确：Enveda 完成 3.11 亿美元 E 轮，估值 20 亿美元，由 Catalio Capital Management 领投，Iconiq 等参投，估值较 12 个月前翻倍。公司用 AI 从植物和微生物中寻找药物，目前有多款候选药进入人体临床试验，包括针对严重皮肤病的药物和帮助停用 GLP-1 后维持减重的药物。文中也明确承认 AI 尚未产出任何获 FDA 批准的药物，未夸大成果。局限是内容为融资简讯，缺少临床数据、试验阶段和疗效细节，信息密度一般。
72
正文
In Brief
Posted:
12:31 PM PDT · September 23, 2026
Image Credits:Viswa Colluru / Enveda
Marina Temkin
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Enveda, a biotech startup that uses AI to discover new drugs in the natural world, has raised a $311 million Series E at a $2 billion valuation. The fresh funding, which was led by Catalio Capital Management, with participation from Iconiq and others, doubles the valuation Enveda achieved 12 months ago.
The idea behind Enveda is that powerful medicines could be harnessed from plants and microbes, rather than synthesized from scratch in a lab. Viswa Colluru, an early employee of Recursion Pharmaceuticals, founded Enveda in 2019 to speed up the process of discovering these new drugs using AI and other techniques.
While AI hasn’t yet produced any FDA-approved drugs, Enveda is among the wave of companies advancing AI-discovered candidates into human clinical trials. The startup is currently testing several drugs in patients, including one targeting severe skin conditions and another designed to help maintain weight loss after stopping GLP-1s.
Topics
AI, Biotech & Health, clinical trials, Enveda, Startups
Newsletters
See More
Subscribe for the industry’s biggest tech news
Related
Startups
Modal Motors is trying to cut China out of electric motors entirely
Sean O'Kane
27 minutes ago
Media & Entertainment
Disney+ and Hulu add to the growing trend of streaming inflation
Lauren Forristal
1 hour ago
Transportation
Zoox grounds Atlanta test fleet after workers report toxic gas exposure symptoms
Sean O'Kane
2 hours ago
Latest in Biotech & Health
In Brief
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Marina Temkin
35 seconds ago
TechCrunch Disrupt 2026
3 days left to save up to $200 and make impactful connections at TechCrunch Disrupt 2026
TechCrunch Events
6 hours ago
TechCrunch Disrupt 2026
Exhibit tables added: One last chance to showcase your startup at TechCrunch Disrupt 2026
TechCrunch Events
1 day ago